ArticleArchives of osteoporosis2025
Comparable fracture risk between orexin and melatonin receptor agonists: integrating active-comparator and population-based evidence.
Kei Muroi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.